News For VPHM From The Last 14 Days Check below for free stories on VPHM the last two weeks.
There are 6 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 8, 2012
|
| 09:21 EDT |  | VPHM |
|
|
February 7, 2012
|
| 09:27 EDT |  | VPHM |
| theflyonthewall.com: | Pre-market top 5 losers | | The following stocks were the top percentage losers before the open on solid volume of at least 50,000 shares, trading at over $10 the prior day. VPHM (4.2%), WAG (2.3%), SCHW (1.6%), VOD (1.3%). Only four stocks met the criteria at time of writing. :theflyonthewall.com |
| | 09:18 EDT |  | VPHM |
| theflyonthewall.com: | ViroPharma weakness on FDA letter a buying opportunity, says Piper Jaffray | | Piper Jaffray views the sell-off in ViroPharma shares after the company received a Complete Response Letter from the FDA as a buying opportunity. Piper thinks the delay appears relatively minor and points out that ViroPharma remains confident of receiving approval of the expanded facility this year. :theflyonthewall.com |
| | 07:37 EDT |  | VPHM |
| theflyonthewall.com: | ViroPharma receives FDA response to letter regarding Cinryze | | ViroPharma announced the FDA issued a complete response letter regarding Cinryze industrial scale manufacturing expansion activities. Specifically, the FDA has three comments related to a portion of the cleaning validation for industrial scale manufacturing, of which only one requires additional unplanned activity. The company expects that the additional activity required to address this comment can be completed in a short time frame. The FDA also noted that it has not yet completed the review of ViroPharma's January 2012 updated responses to observations specific to the September 2011 inspection of the Amsterdam facility. :theflyonthewall.com |
|
|
February 1, 2012
|
| 11:33 EDT |  | VPHM |
| theflyonthewall.com: | ViroPharma management to meet with JMP Securities | | Meeting to be held in Boston on February 8 hosted by JMP Securities. :theflyonthewall.com |
| | 07:04 EDT | | VPHM |
| theflyonthewall.com: | ViroPharma manufacturing issues may prevent approval, says Jefferies | | After ordering Form 483s for the recent FDA inspections of both Cinryze plants, Jefferies believes manufacturing issues remain outstanding that could prevent FDA approval of Cinryze expanded manufacturing, which is expected within the next week. However, the firm says a complete response letter would only be a minor setback, and keeps a Buy rating on ViroPharma shares. :theflyonthewall.com |
|
|
|
Subscribe for More Information